News
-
26/05/14
2026/05/14
管理员
Aniview Support Nanodrug Development Research: An LRP-1/CD44-targeted regorafenib nanodelivery system combats peritoneal metastasis of colorectal cancer through anti-angiogenic and synergistic cytotox
New progress has been made in the development of targeted nanomedicines for peritoneal metastasis of colorectal cancer.
Learn More -
26/05/14
2026/05/14
管理员
New Publication in Cell: AniView Supports Mitochondrial Transfer Therapy Research
New progress has been made in organelle therapy based on mitochondrial capsule delivery systems for the treatment of Parkinson’s disease and other mitochondrial dysfunction-related disorders.
Learn More -
26/05/04
2026/05/04
管理员
Aniview Support Tumor Theranostics Research: A ternary heterostructured nanocrystal featuring an S-scheme heterojunction for enhanced penetration and ROS-amplified tumor ablation
New progress has been made in multifunctional nanocatalytic tumor theranostics.
Learn More -
26/05/04
2026/05/04
管理员
PlantView Support Poplar Rust Resistance Research: Regulation of poplar rust resistance through the interaction between transcription factor PsERF117 and PR10.18
New progress has been made in the molecular regulatory mechanisms of poplar resistance to rust fungi.
Learn More -
26/04/28
2026/04/28
管理员
Aniview Support Skin Wound Healing and Regenerative Medicine : A Fibrous Scaffold Loaded with BMSC-Derived Apoptotic Bodies Promotes Wound Healing via Inducing Macrophage Polarization
New progress has been made in skin wound repair and regenerative medicine, particularly through the regulation of macrophage polarization.
Learn More -
26/04/28
2026/04/28
管理员
AACR 2026 - Returning to AACR with New Solutions for Oncology Research
From April 17 to 22, 2026, the Annual Meeting of the American Association for Cancer Research (AACR) was held at the San Diego Convention Center in California, USA.
Learn More -
26/04/28
2026/04/28
管理员
Aniview Support Cancer Immunotherapy Research: Identification of ADAM12 as a Fibroblast Checkpoint via Single-Cell Screening
New progress has been made in identifying novel targets for cancer immunotherapy through single-cell screening.
Learn More -
26/04/20
2026/04/20
管理员
Aniview Support Tumor Immunotherapy Research: An Epigenetic Nano-Agonist Promotes T Cell Priming, Recruitment, and Reactivation in PD-L1–Resistant Tumors
New progress has been made in the field of immunotherapy for PD-L1–resistant tumors.
Learn More